Galectin-3 can bind to the Trem2, activate microglia, and induce neuroinflammatory responses in an AD mouse model, our recent study confirmed that inhibition of endogenous Trem2 ligand ameliorates DCD by inhibiting oxidative stress and neuroinflammation (53). The gene discussed is TREM2; the disease is Alzheimer disease.